Long-acting reversible contraceptives: Intrauterine devices and the contraceptive implant

Obstetrics and Gynecology

Volumn 117, Issue 3, 2011, Pages 705-719

  Espey, Eve ^a   Ogburn, Tony ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; ETONOGESTREL; GESTAGEN; LEVONORGESTREL;

ADOLESCENT PREGNANCY; BREAST FEEDING; COST EFFECTIVENESS ANALYSIS; EMERGENCY CONTRACEPTION; ENDOMETRIOSIS; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FOOD AND DRUG ADMINISTRATION; GALLBLADDER DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUATION DISORDER; NULLIPARA; OBESITY; OVULATION INHIBITION; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SEIZURE; SMOKING; SPONTANEOUS ABORTION; TROPHOBLASTIC TUMOR; UNITED STATES; UNPLANNED PREGNANCY; UTERINE CERVIX CANCER; UTERINE CERVIX MUCOSA; UTERUS MYOMA; UTERUS PERFORATION;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DRUG IMPLANTS; FEMALE; HUMANS; INTRAUTERINE DEVICES;

EID: 79952020387     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820ce2f0     Document Type: Review

References (90)

1. Grimes DA. Forgettable contraception. Contraception 2009;80(6):497-9.
2. World Health Organization. Mechanism of action, safety and efficacy of intrauterine devices. Technical report series #753. Geneva: WHO; 1987.
3. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008, Vital Health Stat 23 2010;1-44.
4. Trussell J. Contraceptive failure in the United States. Contraception 2004;70:89-96. (Pubitemid 38993483)
5. Trussell J, Wynn LL. Reducing unintended pregnancy in the United States. Contraception 2008;771:1-5.
6. Institute of Medicine. Initial national priorities for comparative effectiveness research. Washington (DC): The National Academies Press; 2009.
7. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
8. Mansour D, Korver T, Marintcheva-Petrova M, Fraser I. The effects of Implanon on menstrual bleeding patterns. Eur J Contraception Reprod Healthcare 2008;13(S1):13-28. (Pubitemid 351364453)
9. Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009;91:1646-53.
10. Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Morb Mortal Wkly Rep 2010;59:52-63.
11. Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt H, et al. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010;82:243-9.
12. Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. ACOG Committee Opinion No. 450. American College of Obstetricians and Gynecologists. Available at: http://www.acog.org/ publications/committee-opinions/co450.cfm. Retrieved August 10, 2010.
13. Intrauterine Device and Adolescents. ACOG Committee Opinion No. 392. American College of Obstetricians and Gynecologists. Available at: http://www.acog.org/publications/committee-opinions/co392.cfm. Retrieved August 10, 2010.
14. Intrauterine device. ACOG Practice Bulletin No. 59. American College of Obstetricians and Gynecologists. Available at: http://www.acog.org/publications/ educational-bulletins/pb059.cfm. Retrieved August 10, 2010.
15. Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No. 73. American College of Obstetricians and Gynecologists. Available at: http://www.acog.org/publications/educational- bulletins/pb073.cfm. Retrieved August 10, 2010.
16. Noncontraceptive uses of hormonal contraceptives. ACOG Practice Bulletin No. 110. American College of Obstetricians and Gynecologists. Available at: http://www.acog.org/publications/educational-bulletins/pb110.cfm. Retrieved August 10, 2010.
17. Lyus R, Lohr P, Prage S, Board of the Society of Family Planning. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception 2010;81:367-71.
18. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785-8.
19. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;16:356:1013-9.
20. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzmán-Rodríguez R R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345:561-7. (Pubitemid 32772097)
21. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195:1272-7. (Pubitemid 44635393)
22. Sääv I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 2007;22:2647-52.
23. Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. Combination oral contraceptive. The Cochrane Database of Systemaatic Reviews 2009, Issue 3. Art. No.: CD007373.
24. Fleming KL, Sokoloff A, Raine TR. Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception 2010;82:178-82.
25. Gamble SB, Strauss LT, Parker WY, Cook DA, Zane SB, Hamdan S. Abortion surveillance - United States, 2005. MMWR Morb Mortal Wkly Rep 2008;57:1-32.
26. Grimes DA, Lopez LM, Schulz KF, Stanwood NL. Immediate postabortal insertion of intrauterine devices. Combination oral contraceptives. The Cochrane. Database of Systematic Reviews 2010, Issue 6. Art. No.: CD001777.
27. Creinin MD, Bednarek PH, Reeves MF, Cwiak CA, Espey E. Incomplete and failed abortion following immediate or delayed postaspiration IUD insertion. Contraception 2009;80:203.
28. Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception, 2008;78:143-8.
29. Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception 2008;78:149-54.
30. Roberts H, Silva M, Xu S. Post abortion contraception and its effect on repeat abortions in Auckland, New Zealand. Contraception 2010;82:260-5.
31. Grimes DA, Lopez LM, Schulz KF, Van Vliet HAAM, Stanwood NL. Immediate post-partum insertion of intrauterine devices. Combination oral contraceptives. The Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No.: CD003036.
32. D'Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception 2007;75:82-7.
33. Ogburn JA, Espey E, Stonehocker J. Barriers to intrauterine device insertion in postpartum women. Contraception 2005;72:426-9. (Pubitemid 41676832)
34. Folger SG, Curtis KM, Tepper NK, Gaffield ME, Marchbanks PA. Guidance on medical eligibility criteria for contraceptive use: identification of research gaps. Contraception 2010;82:113-8.
35. Wu S, Godfrey EM, Wojdyla D, Dong J, Cong J, Wang C, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117:1205-10.
36. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002;99:275-80. (Pubitemid 34114001)
37. Harper CC, Blum M, de Bocanegra HT, Darney PD, Speidel JJ, Policar M, et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol 2008;111:1359-69.
38. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010;203:115.e1-7.
39. Hubacher D, Grimes D. Noncontraceptive health benefits of intrauterine devices: A systematic review, CME review article. Obstet Gynecol Surv 2002:57:120-8. (Pubitemid 34132150)
40. Buttini MJ, Jordan SJ, Webb PM. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review. Aust N Z J Obstet Gynaecol 2009;49:316-22.
41. Varma R, Sinha D, Gupta JK. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - a systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol 2006;125:9-28.
42. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive device: a multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994;61:70-7. (Pubitemid 24030681)
43. Lethaby A, Cooke I, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Combination oral contraceptives. The Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD002126.
44. Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. J Obstet Gynaecol Can 2009;31:340-7.
45. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up. JAMA 2004;291:1456-1463. (Pubitemid 38543736)
46. Marjoribanks J Lethaby A, Farquhar C. Surgery compared with medical therapy for heavy menstrual bleeding. Combination oral contraceptives.The Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003855.
47. Zapata LB, Whiteman MK, Tepper NK, Jamieson DJ, Marchbanks PA, Curtis KM. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception 2010;82:41-55.
48. Andersson K, Ryde-Blomqvist E, Lindell K, Odlind V, Milsom I. Perforations with intrauterine devices. Report from a Swedish survey. Contraception 1998;57:251-5.
49. Markovitch O, Klein Z, Gidoni Y, Holzinger M, Beyth Y. Extrauterine mislocated IUD: is surgical removal mandatory? Contraception 2002;66:105-8.
50. Ozgun MT, Batukan C, Serin IS, Ozcelik B, Basbug M, Dolanbay M. Surgical management of intra-abdominal mislocated intrauterine devices. Contraception 2007;75:96-100. (Pubitemid 46108727)
51. Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception 1995;52:23-34.
52. Furlong LA. Ectopic pregnancy risk when contraception fails. A review. J Reprod Med 2002;47:881-5.
53. Food and Drug Administration. Second report on intrauterine contraceptive devices. Washington (DC): Food and Drug Administraction; 1978.
54. Selected practice recommendations for contraceptive use. 2nd ed. Geneva (Switzerland); 2004. Available at: http://whqlibdoc.who.int/publications/2004/ 9241562846.pdf. Retrieved August 1, 2010.
55. Ganer H, Levy A, Ohel I, Sheiner E. Pregnancy outcome in women with an intrauterine device. Am J Obstet Gynecol 2009;201:381.e1-5.
56. U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Prevnetive Services Task Force recommendation statement. Ann Intern Med 2007;147:128-34.
57. U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med 2005;3:263-7.
58. Skjeldestad FE, Halvorsen LE, Kahn H, Nordbø SA, Saake K. IUD users in Norway are at low risk for genital C. trachomatis infection. Contraception 1996;54:209-12. (Pubitemid 26398616)
59. Faúndes A, Telles E, Cristofoletti ML, Faúndes D, Castro S, Hardy E. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception 1998;58:105-9. (Pubitemid 28449364)
60. Lewis LN, Doherty DA, Hickey M, Skinner SR. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception 2010;81:421-6.
61. Stevens-Simon C, Kelly L, Kulick R. A village would be nice but ... it takes a long-acting contraceptive to prevent repeat adolescent pregnancies. Am J Prev Med 2001;21:60-5. (Pubitemid 32552008)
62. Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, Hout J, Bennink HC. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 2000;15:118-22. (Pubitemid 30035110)
63. Croxatto HB, Urbancsek J, Massai R, Coelingh Bennink H, van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Hum Reprod 1999;14:976-81. (Pubitemid 29176477)
64. Otero Flores J, Balderas M, Bonilla C, Vazquez-Estrada L. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. Int J Gynecol Obstet 2005;90:228-33. (Pubitemid 41138922)
65. Graesslin O, Korver T. The contraceptive efficacy of Implanon: A review of clinical trials and marketing experience. Eur J Contraception Reprod Health Care 2008;13(S1):4-12. (Pubitemid 351364455)
66. Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 2009;80:519-26.
67. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, Thaithumyanon P, Punnahitananda S, Tosukhowong P, et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine device. Contraception 2000;62:239-46. (Pubitemid 32126657)
68. Taneepanichskul S, Reinprayoon D, Thaithumyanon P, Praisuwanna P, Tosukhowong P, Dieben T. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 2006;73:368-71. (Pubitemid 43375097)
69. Funk S, Miller MM, Mishell Dr Jr, Archer DF, Poindexter A, Schmidt J, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319-26. (Pubitemid 40602307)
70. Walch K, Unfried G, Huber J, Kurz C, van Trotsenburg M, Pernicka E, et al. Implanon compared with medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis-a pilot study. Contraception 2009;79:29-34.
71. Yisa SB, Okenwa AA, Husemeyer RP. Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon). J Fam Plann Reprod Health Care 2005;31:67-70. (Pubitemid 40127836)
72. Shokeir T, Amr M, Abdelshaheed M. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Arch Gynecol Obstet 2009;280:437-43.
73. Power J, French R, Cowan F. Subdermal implantable contraceptives compared with other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy. Combination oral contraceptives. The Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD001326.
74. Levine JP, Sinofsky FE, Christ MF, Implanon US Study Group. Assessment of Implanon insertion and removal. Contraception 2008;78:409-17.
75. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from post-marketing experience in Australia. Contraception 2005;71:306-8. (Pubitemid 40410081)
76. Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception 2006;73:325-30. (Pubitemid 43375088)
77. Bitzer J, Tschudin S, Alder J. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contraception Reprod Health Care 2004;9:278-84. (Pubitemid 40093198)
78. Weisberg E, Hickey M, Plmer D, O'Connor V, Salamonsen L, Findlay J, et al. A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Hum Reprod 2009;25:1852-61.
79. Abdel-Aleem H, d'Arcangues C, Vogelsong KM, Gulmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Combination oral contraceptives. The Cochrane Database Systematic Reviews 2007, Issue 2. Art. No.: CD003449. DOI: 10.1002/14651858.CD003449.pub3.
80. Merki-Feld G, Imthurn B, Seifert B. Effects of the progestgen- only contraceptive implant Implanon on cardiovascular risk factors. Clin Endocrinol. 2008;68:355-60. (Pubitemid 351257852)
81. Biswas A, Biswas S, Viegas OA. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests - a randomized comparative study with Norplant implants. Contraception 2004;70:379-82. (Pubitemid 39422514)
82. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception 2009;79:5-14.
83. Mavranezouli I, LARC Guideline Development Group. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Hum Reprod 2008;23:1338-45.
84. Guttmacher Institute, Community Health Centers and Family Planning. Improving contraceptive use. In Brief, 2008 Series, No. 1. New York (NY): Guttmacher, 2008. Available at: http://www.guttmacher.org/pubs/2008/05/09/ ImprovingContraceptiveUse.pdf. Retrieved November 30, 2010.
85. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999;181:1263-9.
86. Stanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 2002;187:1699-708. (Pubitemid 36026710)
87. Davies G, Feng L, Newton J, Van Beek A, Coelingh-Bennink J. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception 1993;47:251-61. (Pubitemid 23107285)
88. Croxatto H. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 2002;65:21-7. (Pubitemid 34175235)
89. Makarainen L, Van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril. 1998;69:714-21. (Pubitemid 28188469)
90. Vessey MP, Lawless M, McPherson K, Yeates D. Fertility after stopping use of intrauterine contraceptive device. Br Med J 1983;286:106. (Pubitemid 13147576)